Epicatechin gallate-induced expression of NAG-1 is associated with growth inhibition and apoptosis in colon cancer cells

Carcinogenesis

Volumn 25, Issue 12, 2004, Pages 2425-2432

  Baek, Seung Joon ^a   Kim, Jong Sik ^b   Jackson, Felix R ^a   Eling, Thomas E ^b   McEntee, Michael F ^a   Lee, Seong Ho ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; CATECHIN; EPICATECHIN GALLATE; GREEN TEA EXTRACT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NONSTEROID ANTIINFLAMMATORY DRUG ACTIVATED GENE PROTEIN; PROTEIN NAG 1; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL LINE; COLON CANCER; CONCENTRATION RESPONSE; GENE EXPRESSION REGULATION; GENE INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TEA;

ANTIOXIDANTS; APOPTOSIS; CATECHIN; COLONIC NEOPLASMS; CYTOKINES; G1 PHASE; HCT116 CELLS; HUMANS; POLY(ADP-RIBOSE) POLYMERASES; PROMOTER REGIONS (GENETICS); TEA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 10344233656     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh255     Document Type: Article

References (54)

1. Potter,J.D., Slattery,M.L., Bostick,R.M. and Gapstur,S.M. (1993) Colon cancer: a review of the epidemiology. Epidemiol. Rev., 15, 499-545.
2. Holt,P.R. (1999) Dairy foods and prevention of colon cancer: human studies. J. Am. Coll. Nutr., 18, 379S-391S.
3. Reddy,B.S. and Rao,C.V. (2002) Novel approaches for colon cancer prevention by cyclooxygenase-2 inhibitors. J. Environ. Pathol. Toxicol. Oncol., 21, 155-164.
4. Mason,J.B. (2002) Nutritional chemoprevention of colon cancer. Semin. Gastrointest. Dis., 13, 143-153.
5. Wenzel,U., Kuntz,S., Brendel,M.D. and Daniel,H. (2000) Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. Cancer Res., 60, 3823-3831.
6. Kohri,T., Suzuki,M. and Nanjo,F. (2003) Identification of metabolites of (-)-epicatechin gallate and their metabolic fate in the rat. J. Agric. Food Chem., 51, 5561-5566.
7. Vaidyanathan,J.B. and Walle,T. (2003) Cellular uptake and efflux of the tea flavonoid (-)epicatechin-3-gallate in the human intestinal cell line Caco-2. J. Pharmacol. Exp. Ther., 307, 745-752.
8. Surh,Y. (1999) Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances [In Process Citation]. Mutat. Res., 428, 305-327.
9. Katiyar,S.K. and Mukhtar,H. (1997) Inhibition of phorbol ester tumor promoter 12-O-tetradecanoylphorbol-13-acetate-caused inflammatory responses in SENCAR mouse skin by black tea polyphenols. Carcinogenesis, 18, 1911-1916.
10. Dong,Z., Huang,C., Brown,R.E. and Ma,W.-Y. (1997) Inhibition of activator protein 1 activity and neoplastic transformation by aspirin. J. Biol. Chem., 272, 9962-9970.
11. Cao,Y. and Cao,R. (1999) Angiogenesis inhibited by drinking tea. Nature, 398, 381.
12. Lamy,S., Gingras,D. and Beliveau,R. (2002) Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation. Cancer Res., 62, 381-385.
13. Hofmann,C.S. and Sonenshein,G.E. (2003) Green tea polyphenol epigallocatechin-3 gallate induces apoptosis of proliferating vascular smooth muscle cells via activation of p53. FASEB J., 17, 702-704.
14. Naasani,I., Oh-hashi,F., Oh-hara,T., Feng,W.Y., Johnston,J., Chan,K. and Tsuruo,T. (2003) Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo. Cancer Res., 63, 824-830.
15. Baek,S.J., Kim,K.S., Nixon,J.B., Wilson,L.C. and Eling,T.E. (2001) Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities. Mol. Pharmacol., 59, 901-908.
16. Bootcov,M.R., Bauskin,A.R., Valenzuela,S.M. et al. (1997) MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc. Natl Acad. Sci. USA, 94, 11514-11519.
17. Li,P.X., Wong,J., Ayed,A., Ngo,D., Brade,A.M., Arrowsmith,C., Austin,R.C. and Klamut,H.J. (2000) Placental TGF-β is a downstream mediator of the growth arrest and apoptosic response of tumor cells to DNA damage and p53 overexpression. J. Biol. Chem., 275, 20127-20135.
18. Paralkar,V.M., Vail,A.L., Grasser,W.A., Brown,T.A., Xu,H., Vukicevic,S., Ke,H.Z., Qi,H., Owen,T.A. and Thompson,D.D. (1998) Cloning and characterization of a novel member of the transforming growth factor-β/bone morphogenetic protein family. J. Biol. Chem., 273 13760-13767.
19. Bottner,M., Laaff,M., Schechinger,B., Rappold,G., Unsicker,K. and Suter-Crazzolara,C. (1999) Characterization of the rat, mouse and human genes of growth/differentiation factor-15/macrophage inhibiting cytokine-1 (GDF-15/MIC-1). Gene, 237, 105-111.
20. Hromas,R., Hufford,M., Sutton,J., Xu,D., Li,Y. and Lu,L. (1997) PLAB, a novel placental bone morphogenetic protein. Biochim. Biophys. Acta, 1354, 40-44.
21. Kim,K.S., Baek,S.J., Flake,G.P., Loftin,C.D., Calvo,B.F. and Eling,T.E. (2002) Expression and regulation of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) in human and mouse tissue. Gastroenterology, 122, 1388-1398.
22. Liu,T., Bauskin,A.R., Zaunders,J., Brown,D.A., Pankurst,S., Russell,P.J. and Breit,S.N. (2003) Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells. Cancer Res., 63, 5034-5040.
23. Baek,S.J., Wilson,L.C., Lee,C.H. and Eling,T.E. (2002) Dual function of nonsteroidal anti-inflammatory drugs (NSAIDs): inhibition of cyclooxygenase and induction of NSAID-activated gene. J. Pharmacol. Exp. Ther., 301, 1126-1131.
24. Baek,S.J., Wilson,L.C. and Eling,T.E. (2002) Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53. Carcinogenesis, 23, 425-434.
25. Wilson,L.C., Baek,S.J., Call,A. and Eling,T.E. (2003) Nonsteroidal anti-inflammatory drug-activated gene (NAG-1) is induced by genistein through the expression of p53 in colorectal cancer cells. Int. J. Cancer, 105, 747-753.
26. Bottone,F.G.,Jr, Baek,S.J., Nixon,J.B. and Eling,T.E. (2002) Diallyl disulfide (DADS) induces the antitumorigenic NSAID-activated gene (NAG-1) by a p53-dependent mechanism in human colorectal HCT 116 cells. J. Nutr., 132, 773-778.
27. Baek,S.J., Kim,J.S., Nixon,J.B., DiAugustine,R.P. and Eling,T.E. (2004) Expression of NAGA-1, a Transforming Growth Factor-β Superfamily Member, by Troglitazone Requires the Early Growth Response Gene EGR-1. J. Biol. Chem., 279, 6883-6892.
28. Monks,A., Harris,E., Hose,C., Connelly,J. and Sausville,E.A. (2003) Genotoxic profiling of MCF-7 breast cancer cell line elucidates gene expression modifications underlying toxicity of the anticancer drug 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole. Mol. Pharmacol., 63, 766-772.
29. Newman,D., Sakaue,M., Koo,J.S., Kim,K.S., Baek,S.J., Eling,T. and Jetten,A.M. (2003) Differential regulation of nonsteroidal anti-inflammatory drug-activated gene in normal human tracheobronchial epithelial and lung carcinoma cells by retinoids. Mol. Pharmacol., 63, 557-564.
30. Baek,S.J., Horowitz,J.M. and Eling,T.E. (2001) Molecular cloning and characterization of human nonsteroidal anti-inflammatory drug-activated gene promoter. Basal transcription is mediated by Sp1 and Sp3. J. Biol. Chem., 276, 33384-33392.
31. Baek,S.J., Wilson,L.C., Hsi,L.C. and Eling,T.E. (2003) Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity. J. Biol. Chem., 278, 5845-5853.
32. Cabrera,C., Gimenez,R, and Lopez,M.C. (2003) Determination of tea components with antioxidant activity. J. Agric. Food Chem., 51, 4427-4435.
33. Hastak,K., Gupta,S., Ahmad,N., Agarwal,M.K., Agarwal,M.L. and Mukhtar,H. (2003) Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Oncogene 22, 4851-4859.
34. Tan,M., Wang,Y., Guan,K. and Sun,Y. (2000) PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway. Proc. Natl Acad. Sci. USA, 97, 109-114.
35. Chen,C., Shen,G., Hebbar,V., Hu,R., Owuor,E.D. and Kong,A.N. (2003) Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells. Carcinogenesis, 24, 1369-1378.
36. Armstrong,L.C. and Bornstein,P. (2003) Thrombospondins 1 and 2 function as inhibitors of angiogenesis. Matrix Biol., 22, 63-71.
37. Thomas,R., True,L.D., Lange,P.H. and Vessella,R.L. (2001) Placental bone morphogenetic protein (PLAB) gene expression in normal, premalignant and malignant human prostate: relation to tumor development and progression. Int. J. Cancer, 93, 47-52.
38. Iczkowski,K.A. and Pamazis,C.G. (2003) Overexpression of NSAID-activated gene product in prostate cancer. Int. J. Surg. Pathol. 11, 159-166.
39. Karan,D., Chen,S.J., Johansson,S.L., Singh,A.P., Paralkar,V.M., Lin,M.F. and Batra,S.K. (2003) Dysregulated expression of MIC-1/PDF in human prostate tumor cells. Biochem. Biophys. Res. Commun., 305, 598-604.
40. Welsh,J.B., Sapinoso,L.M., Su,A.I., Kern,S.G., Wang-Rodriguez,J., Moskaluk.C.A., Frierson,H.F.,Jr and Hampton,G.M. (2001) Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res., 61, 5974-5978.
41. Arab,L. and Il'yasova,D. (2003) The epidemiology of tea consumption and colorectal cancer incidence. J. Nutr., 133, 3310S-3318S.
42. Johnson,M.K. and Loo,G. (2000) Effects of epigallocatechin gallate and quercetin on oxidative damage to cellular DNA. Mutat. Res. 459, 211-218.
43. Hai,T. and Hartman,M.G. (2001) The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene, 273, 1-11.
44. Hai,T., Wolfgang,C.D., Marsee,D.K., Allen,A.E. and Sivaprasad,U. (1999) ATF3 and stress responses. Gene Expr., 7 321-335.
45. Iizaka,M., Furukawa,Y., Tsunoda,T., Akashi,H., Ogawa,M. and Nakamura,Y. (2002) Expression profile analysis of colon cancer cells in response to sulindac or aspirin. Biochem. Biophys. Res. Commun., 292, 498-512.
46. Bottone,F.G.,Jr, Martinez,J.M., Collins,J.B., Afshari,C.A. and Eling,T.E. (2003) Gene modulation by the cyclooxygenase inhibitor, sulindac sulfide, in human colorectal carcinoma cells: possible link to apoptosis. J. Biol. Chem., 278, 25790-25801.
47. Fan,F., Jin,S., Amundson,S.A. et al. (2002) ATF3 induction following DNA damage is regulated by distinct signaling pathways and overexpression of ATF3 protein suppresses cells growth. Oncogene, 21, 7488-7496.
48. Weinreb,O., Mandel,S. and Youdim,M.B. (2003) Gene and protein expression profiles of anti- and pro-apoptotic actions of dopamine, R-apomorphine, green tea polyphenol (-)-epigallocatechin-3-gallate and melatonin. Ann. N. Y. Acad. Sci., 993, 351-361, 387-393.
49. Adhami,V.M., Ahmad,N. and Mukhtar,H. (2003) Molecular targets for green tea in prostate cancer prevention. J. Nutr., 133, 2417S-2424S.
50. Lu,H., Meng,X., Li,C., Sang,S., Patten,C., Sheng,S., Hong,J., Bai,N., Winnik,B., Ho,C.T. and Yang,C.S. (2003) Glucuronides of tea catechins: enzymology of biosynthesis and biological activities. Drug Metab. Dispos., 31, 452-461.
51. Nie,G., Jin,C., Cao,Y., Shen,S. and Zhao,B. (2002) Distinct effects of tea catechins on 6-hydroxydopamine-induced apoptosis in PC12 cells. Arch. Biochem. Biophys., 397, 84-90.
52. Wang,X., Song,K.S., Guo,Q.X. and Tian,W.X. (2003) The galloyl moiety of green tea catechins is the critical structural feature to inhibit fatty-acid synthase. Biochem. Pharmacol., 66, 2039-2047.
53. Yang,C.S., Chen,L., Lee,M.J., Balentine,D., Kuo,M.C. and Schantz,S.P. (1998) Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol. Biomarkers Prev., 7, 351-354.
54. Yang,C.S., Chung,J.Y., Yang,G., Chhabra,S.K. and Lee,M.J. (2000) Tea and tea polyphenols in cancer prevention. J. Nutr., 130, 472S-478S.